Collaborative Arrangements (Tables)

9 Months Ended

Sep. 30, 2015

Schedule of Recognized Collaborative Revenue

During the three and nine months ended September 30, 2015 and 2014, the Company recognized the following revenues attributable to the Janssen NV collaboration:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
	(in thousands)
Royalty revenues (INCIVO)	$	158	$	2,284	$	1,742	$	12,917
Collaborative revenues (telaprevir)	441		1,390		1,620		4,262
Total revenues attributable to the Janssen NV collaboration	$	599	$	3,674	$	3,362	$	17,179

Fair Value Of Consideration Transferred

The consideration paid and the preliminary fair value of the contingent milestone and royalty payments payable by the Company pursuant to the agreement are set forth in the table below:



	June 4, 2015
	(in thousands)
Up-front payment	$	80,000
Fair value of contingent milestone and royalty payments	175,340
Total	$	255,340

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the preliminary fair values of the assets and liabilities recorded on the effective date of the agreement:



	June 4, 2015
	(in thousands)
Intangible assets	$	255,340
Goodwill	10,468
Deferred tax liability	(91,023		)
Net other assets (liabilities)	(10,468		)
Net assets attributable to noncontrolling interests	$	164,317

Schedule of Collaborative Arrangement Activity Net Loss Attributable to Noncontrolling Interest

The Company did not have any consolidated VIEs for the three and nine months ended September 30, 2014. An aggregate summary of net loss attributable to noncontrolling interest related to the Company's VIEs for the three and nine months ended September 30, 2015 is as follows:



	Three Months Ended September 30, 2015			Nine Months Ended September 30, 2015
	(in thousands)
Loss attributable to noncontrolling interest before provision for income taxes	$	(1,743	)	$	(3,322	)
Provision for income taxes	(777		)	(30,367		)
Increase in fair value of contingent milestone and royalty payments	3,853			2,780
Net (income) loss attributable to noncontrolling interest	$	1,333		$	(30,909	)

Schedule Of Collaborative Arrangement Summary Of Items Related To Variable Interest Entities

The following table summarizes items related to the Company's VIEs included in the Company's condensed consolidated balance sheets as of the dates set forth in the table:



	September 30, 2015		December 31, 2014
	(in thousands)
Restricted cash and cash equivalents (VIE)	$	75,765	$	8,418
Prepaid expenses and other current assets	3,057		268
Intangible assets	284,340		29,000
Goodwill	19,391		8,923
Other assets	461		42
Accounts payable	1,115		189
Accrued expenses and other current liabilities	32,519		3,891
Deferred tax liability, net	110,360		11,544
Other liabilities	300		300
Noncontrolling interest	154,585		21,177